Potential effects of dacomitinib/dacomitinib on the cardiovascular system
Dacomitinib/As an innovative targeted therapy drug, Dacomitinib plays an important role in the treatment of malignant tumors such as non-small cell lung cancer. However, like many drugs, the use of dacomitinib may also have certain effects on the patient's physiological functions, especially the potential impact on the cardiovascular system that has attracted much attention.
Studies have shown that dacomitinib may cause certain effects on the cardiovascular system. Specifically, it may increase the risk of irregular heartbeats and heart failure. Arrhythmia usually manifests as abnormal heartbeat rhythm, which may cause patients to feel palpitation, chest tightness and other discomforts; while heart failure means that the heart cannot effectively pump enough blood to all parts of the body, which may cause patients to feel fatigue, difficulty breathing and other symptoms.
For patients being treated with dacomitinib, if they experience chest pain, palpitations, shortness of breath and other uncomfortable symptoms that may be related to cardiovascular problems, they should seek medical help immediately and clearly inform their doctors about the drugs they are currently using. Based on the patient's specific condition, the doctor may recommend further examinations such as electrocardiogram to evaluate cardiovascular function, and adjust the treatment plan according to the actual situation.
In addition, the use of dacomitinib may be associated with other adverse reactions, such as diarrhea, rash, stomatitis, nail abnormalities, dry skin, loss of appetite, conjunctivitis, weight and hair loss, itching, and nausea. Although these side effects may be inconvenient for patients, they can usually be relieved with appropriate supportive care. While taking dacomitinib, patients should carefully monitor their physical condition, especially for any symptoms related to the cardiovascular system. At the same time, it is crucial to maintain regular communication with the doctor to provide timely feedback on any discomfort, thereby ensuring that the doctor can adjust the treatment plan according to the patient's actual condition and ensure the safety and effectiveness of the treatment process.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)